Stock Research: Fisher & Paykel Healthcare

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Fisher & Paykel Healthcare

NZSE:FPH NZFAPE0001S2
88
  • Value
    8
  • Growth
    91
  • Safety
    Safety
    72
  • Combined
    57
  • Sentiment
    90
  • 360° View
    360° View
    88
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fisher & Paykel Healthcare Corporation Limited designs, manufactures, and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company operates in the medical device industry, with products for hospital and homecare settings. It sells its products in over 120 countries worldwide, including Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, and India. In the last fiscal year, the company had a market cap of $12,544 million, profits of $722 million, revenue of $1,148 million, and 7506 employees.

more
Index
ASX 100
ASX 200
ASX 300
Human Rights
SDG 12
SDG 3
SDG 8
NZSX 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
8 13 26 19
Growth
91 99 49 33
Safety
Safety
72 75 73 59
Sentiment
90 46 58 37
360° View
360° View
88 78 59 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
13 7 3 19
Opinions Change
100 54 83 50
Pro Holdings
n/a 41 59 40
Market Pulse
85 83 83 69
Sentiment
90 46 58 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
8 13 26 19
Growth
91 99 49 33
Safety Safety
72 75 73 59
Combined
57 79 60 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
11 11 14 19
Price vs. Earnings (P/E)
5 3 7 13
Price vs. Book (P/B)
5 7 7 9
Dividend Yield
32 44 55 45
Value
8 13 26 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
83 77 78 10
Profit Growth
76 70 45 10
Capital Growth
66 98 19 95
Stock Returns
47 91 51 51
Growth
91 99 49 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
73 67 77 72
Refinancing
18 22 20 24
Liquidity
100 100 84 83
Safety Safety
72 75 73 59

Similar Stocks

Discover high‑ranked alternatives to Fisher & Paykel Healthcare and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

KT

KOSE:A030200
Country: South Korea
Industry: Integrated Telecommunication
Size: Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: